Relapse Clinical Trials
Conditions / Relapse
Delta Trials tracks 85 clinical trials for Relapse in its publicly accessible dataset. Among the listed trials, 18 open for participant enrollment and 26 trials have reached completion. This research is carried out at 126 clinical sites around the world. An additional 41 trials have active registrations outside the recruiting and completed categories. Since 2020, 6 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
85
Total Trials
18
Recruiting
26
Completed
41
Other Active
6
Terminated since 2020
126
Study Locations
Browse by location (126 total)
- Paris, France 6 trialsAll trials in Paris, France
- Paris, France 6 trialsAll trials in Paris, France
- Rohtak, India 5 trialsAll trials in Rohtak, India
- Chapel Hill, United States 5 trialsAll trials in Chapel Hill, United States
- Bordeaux, France 4 trialsAll trials in Bordeaux, France
- Van, Turkey (türkiye) 4 trialsAll trials in Van, Turkey (türkiye)
- Tianjin, China 4 trialsAll trials in Tianjin, China
- Lille, France 3 trialsAll trials in Lille, France
- Beijing, China 3 trialsAll trials in Beijing, China
- Mannheim, Germany 3 trialsAll trials in Mannheim, Germany
- Guangzhou, China 3 trialsAll trials in Guangzhou, China
- Lyon, France 3 trialsAll trials in Lyon, France
- Montpellier, France 3 trialsAll trials in Montpellier, France
- Montpellier, France 3 trialsAll trials in Montpellier, France
- Toulouse, France 2 trialsAll trials in Toulouse, France
- Nantes, France 2 trialsAll trials in Nantes, France
- Würzburg, Germany 2 trialsAll trials in Würzburg, Germany
- Saint-Étienne, France 2 trialsAll trials in Saint-Étienne, France
- Caen, France 2 trialsAll trials in Caen, France
- Villejuif, France 2 trialsAll trials in Villejuif, France